Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
European Journal of Human Genetics
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
About the society
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
November 2002, Volume 10, Number 11, Pages 753-756
Table of contents    Previous  Abstract  Next   Full text  PDF
Article
Evaluation of BMP4 and its specific inhibitor NOG as candidates in human neural tube defects (NTDs)
Bärbel Felder1, Karolin Stegmann1, Almut Schultealbert1, Frank Geller2, Elisabeth Strehl3, August Ermert4 and Manuela C Koch1

1Zentrum für Humangenetik, Philipps-Universität Marburg, 35037 Marburg, Germany

2Institut für Medizinische Biometrie und Epidemiologie, Philipps-Universität Marburg, 35037 Marburg, Germany

3Kinderklinik der Universität Erlangen, 91054 Erlangen, Germany

4Kinderneurologisches Zentrum des Landes Rheinland-Pfalz, 55122 Mainz, Germany

Correspondence to: Manuela C Koch, Zentrum für Humangenetik, Bahnhofstrae 7, D-35037 Marburg, Germany; Tel: 06421/286 6269;Fax: 06421/286 8920; E-mail: koch2@mailer.uni-marburg.de

Abstract

Neural tube defects (NTD) are among the most common congenital malformations in humans. The current view is that there are no major genes causing NTDs, but combinations of sequence variants in different genes have additive effects on determining the malformation. Therefore it is important to identify such sequence variants to get a better understanding of NTD pathogenesis. Studies on animal models have shown that BMP4 and NOG are involved in the patterning of the neural tube. We therefore performed a single-strand conformation analysis (SSCA) mutation screen for both genes in 179 spina bifida aperta (SBA) patients. Our SSCA screen revealed four missense mutations in BMP4 and one in NOG. It is likely that these mutations have acted together with other gene variants in independently segregating loci as susceptibility factors in these SBA cases. In addition, a case-control association study provides evidence for a genotype disequilibrium of BMP4 polymorphism 455Tright arrowC (V152A) in exon 5. The frequency of the heterozygous 455TC genotype is lower in cases than in controls (nominal P=0.017), although allele frequencies are similar in both groups. A possible explanation for this finding might be that BMP4 455TC heterozygosity at this site is a protective factor in the normal population, although this hypothesis cannot be proven to date.

European Journal of Human Genetics (2002) 10, 753-756. doi:10.1038/sj.ejhg.5200875

Keywords

neural tube defects; spina bifida aperta; BMP4; NOG

Received 8 April 2002; revised 28 June 2002; accepted 10 July 2002
November 2002, Volume 10, Number 11, Pages 753-756
Table of contents    Previous  Abstract  Next   Full text  PDF
Privacy Policy © 2002 Nature Publishing Group